Indonesia shifts lithium imports to Australia, expands EV battery partnerships with China
Indonesia is increasing lithium imports from Australia to boost its electric vehicle (EV) battery supply and advance its EV development…
TCC battery plant fire results in NT$11B loss, exposing challenges in Taiwan’s lithium battery industry
A fire at Molicel’s lithium ternary battery factory, a subsidiary of TCC, revealed serious failures in its firefighting system, which…
Solteam defies EV industry slump with 38% surge in NEV revenue
In a challenging global environment that has dampened growth across the electric vehicle (EV) industry, Solteam held its investor briefing…
Formosa Plastics Group to set new benchmark for efficient, low-carbon battery cell manufacturing at Changbin plant
Formosa Smart Energy’s (FSET) battery cell factory in Changbin Industrial Park is Taiwan’s largest LFP battery manufacturer, with a capacity…
Analysis: AI startups target Chrome as major AI application battleground
Rising AI startups, including OpenAI and Perplexity, have shown interest in acquiring the Google Chrome browser, with Perplexity offering US$34.5…
Kdan Mobile Software partners with Japanese AI search startup for agent ecosystem
Kdan Mobile Software (KDAN) has formed a strategic partnership with Japanese AI search engine startup Felo, with integrated technologies expected…
Market research predicts staggering growth for microLED TV market starting in 2028
The microLED market—considered a “game changer” in the next-generation display panel industry—is expected to enter a rapid growth phase starting…
Applied Materials faces lawsuit from smaller Chinese rival
Chinese semiconductor equipment makers are increasingly taking the offensive in protecting their technology and intellectual property. Beijing E-Town Semiconductor Technology…
TSMC’s top wafer testing partner posts 78% surge as new facility ramps
Xintec Inc., TSMC’s backend packaging and testing unit, posted a strong second-quarter 2025 rebound in wafer probe revenue, driven by…
Tremelimumab–Durvalumab Combo Extends Survival and Improves Cost-Effectiveness Over Sorafenib in Unresectable HCC
Combination therapy with tremelimumab and durvalumab significantly improves survival in liver cancer patients compared to standard sorafenib treatment.